نتائج البحث - "Casper, Jochen"

المساهمون: Olympia Morata Program of the Medical Faculty of the University of Heidelberg, Frankfurter Förderung “Nachwuchswissenschaftler, EUTOS funding program, Carreras leukemia foundation, Universitätsklinikum Heidelberg

المصدر: Journal of Hematology & Oncology ; volume 16, issue 1 ; ISSN 1756-8722

مصطلحات موضوعية: Cancer Research, Oncology, Molecular Biology, Hematology

الإتاحة: https://doi.org/10.1186/s13045-023-01470-0Test

View record in BASE

6

دورية أكاديمية

Are syngeneic donors a viable donor option in allogeneic haematopoietic cell transplantation for MDS? A brief report on behalf of the Chronic Malignancies Working Party of the EBMT and review of current literature.

المساهمون: Université de Lille, Inserm, CHU Lille, Hopital Saint-Louis AP-HP AP-HP, Universiteit Leiden = Leiden University, Leiden University Medical Center LUMC, Azienda Ospedaliero-Universitaria Careggi Firenze AOUC, University of Freiburg Freiburg, CHU Bordeaux, University of Barcelona, University Hospital Düsseldorf, Dél-pesti Centrumkórház - Országos Hematológiai és Infektológiai Intézet Budapest, Hungary, Imperial College London, CHU Clermont-Ferrand, University of Oldenburg, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology MCMCC, King's College Hospital KCH, University-Hospital Munich-Großhadern München, Riga Technical University, Universität Innsbruck Innsbruck, Medical University of Warsaw - Poland, University College London Hospitals NHS Foundation Trust London, UK UCLH, Cleveland Clinic, Università degli Studi di Roma Tor Vergata Roma = University of Rome Tor Vergata, Institut de Recherche Translationnelle sur l'Inflammation (INFINITE) - U1286, Fondazione IRCCS Ca' Granda - Ospedale Maggiore Policlinico, University Hospital of Cologne Cologne

وصف الملف: application/octet-stream

العلاقة: Bone Marrow Transplantation; Bone Marrow Transplant; http://hdl.handle.net/20.500.12210/100576Test

الإتاحة: https://doi.org/20.500.12210/100576Test
https://hdl.handle.net/20.500.12210/100576Test

View record in BASE

7

دورية أكاديمية

Survival advantage of treosulfan plus fludarabine (FT14) compared to busulfan plus fludarabine (FB4) in active acute myeloid leukemia post allogeneic transplantation: an analysis from the European Society for Blood and Marrow Transplantation (EBMT) Acute Leukemia Working Party (ALWP).

المساهمون: Université de Lille, Inserm, CHU Lille, General Hospital of Thessaloniki George Papanikolaou, CHU Saint-Antoine AP-HP, Technische Universität Dresden = Dresden University of Technology TU Dresden, University of Oldenburg, University Hospital Regensburg, Faculty of Medicine in Hradec Kralove Republique Tchèque, Institut de Recherche Translationnelle sur l'Inflammation (INFINITE) - U1286, Ospedale San Raffaele, University Children's Hospital of Essen, University Hospital Düsseldorf, Azienda Ospedaleria Universitaria di Modena, University of Freiburg Freiburg, Hospital General Universitario "Gregorio Marañón" Madrid, Hôpital JeanMinjoz, Technische Universität Munchen - Technical University Munich - Université Technique de Munich TUM, Vanderbilt University Medical Center Nashville, General University Hospital of Patras, Chaim Sheba Medical Center

وصف الملف: application/octet-stream

العلاقة: Bone Marrow Transplantation; Bone Marrow Transplant; http://hdl.handle.net/20.500.12210/106448Test

الإتاحة: https://doi.org/20.500.12210/106448Test
https://hdl.handle.net/20.500.12210/106448Test

View record in BASE